@andreafava reviews options other than renal biopsy in the future of Lupus renal disease. Urine proteomics can detect LN active pathways IL-16, proinflammatory chemokine, linked to LN activity as potential new biomarker? #RNL2024 @RheumNow https://t.co/GoEwu09npd